RB

Rajesh Bhagavatheeswara Iyer

Active Director Director DIN 05120006
DIN 05120006 First appointment Jun 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jun 2013
Shareholding value •••• Premium profile

About Rajesh Bhagavatheeswara Iyer

Data last updated:

Rajesh Bhagavatheeswara Iyer is a Director at Hosur Super Speciality Hospitals Private Limited (since 2013), Director at Poorna Health Private Limited (since 2022) and Director at Valam Health Care Private Limited (since 2025). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹76.81 Cr; the largest is Hosur Super Speciality Hospitals Private Limited at ₹68.55 Cr (FY 2025). Earlier, Rajesh Bhagavatheeswara Iyer was a Partner at Dr. Sudhir Pai Neuro Sciences Llp (from 2014).

DIN 05120006
Primary Designation Director
Industry Healthcare
First Appointment 19 Jun 2013
Oldest Company Age 13 yrs
Largest company Hosur Super Speciality Hospitals Private Limited · ₹68.55 Cr (FY 2025)
Combined revenue ₹76.81 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20132013₹68.55 Cr (FY 2025)Active
Poorna Health Private Limited U85300KA2022PTC159721
Director06 Apr 20222022₹8.26 Cr (FY 2025)Active
Valam Health Care Private Limited U86100TZ2025PTC036643
Director10 Nov 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner21 Jan 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Valam Health Care Private Limited
Poorna Health Private Limited
Hosur Super Speciality Hospitals Private Limited
Dr. Sudhir Pai Neuro Sciences Llp
Premium access

Shareholding and investment profile for Rajesh Bhagavatheeswara Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Bhagavatheeswara Iyer

Rajesh Bhagavatheeswara Iyer currently holds 3 directorships: Hosur Super Speciality Hospitals Private Limited (Director, since 19 Jun 2013, revenue ₹68.55 Cr (FY 2025)); Poorna Health Private Limited (Director, since 06 Apr 2022, revenue ₹8.26 Cr (FY 2025)); Valam Health Care Private Limited (Director, since 10 Nov 2025).

Rajesh Bhagavatheeswara Iyer was first appointed on 19 Jun 2013 as Director at Hosur Super Speciality Hospitals Private Limited. The most recent appointment on record is 10 Nov 2025 at Valam Health Care Private Limited.

The 2 current companies of Rajesh Bhagavatheeswara Iyer that report revenue have a combined latest revenue of ₹76.81 Cr: Hosur Super Speciality Hospitals Private Limited ₹68.55 Cr (FY 2025); Poorna Health Private Limited ₹8.26 Cr (FY 2025).

Rajesh Bhagavatheeswara Iyer held 1 earlier board appointment: Dr. Sudhir Pai Neuro Sciences Llp (Partner, from 21 Jan 2014).

The current boards of Rajesh Bhagavatheeswara Iyer's companies include Chennakesavan Vijie (Hosur Super Speciality Hospitals Private Limited), Kirubakaran Pradeep Kumar (Hosur Super Speciality Hospitals Private Limited), Kurusamy Karthikpandian Sankara Pandian (Hosur Super Speciality Hospitals Private Limited), Meenakshisundaram Senthil (Hosur Super Speciality Hospitals Private Limited), Piramanayagam Subramanian (Hosur Super Speciality Hospitals Private Limited), Prabhudev Kengabharmappa Basappa (Hosur Super Speciality Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available